Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Guillain-Barre Syndrome (GBS)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Early research (Phase 1)Study completedNCT01052935
What this trial is testing

Assess the Persistence of a GBS Antibody in Women Previously Immunized With a GBS Vaccine

Who this might be right for
Group B Streptococcus (GBS) Disease
Novartis 50
Not applicableUnknownNCT05284786
What this trial is testing

Ultrasonography and Electrophysiology in GBS

Who this might be right for
Guillain-Barre Syndrome
Assiut University 45
Not applicableLooking for participantsNCT05212792
What this trial is testing

Genomics and COVID-19 Vaccine Adverse Events

Who this might be right for
Vaccine Adverse Reaction
University of British Columbia 6,325
Not applicableNot Yet RecruitingNCT06896526
What this trial is testing

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

Who this might be right for
Invasive Group B Streptococcus DiseaseGroup B StreptococcusGroup B Streptococcal Infection+3 more
Precia Group 10,000
Testing effectiveness (Phase 2)Study completedNCT03943589
What this trial is testing

Imlifidase in Patients With Guillain-Barré Syndrome

Who this might be right for
Guillain-Barré Syndrome (GBS)
Hansa Biopharma AB 30
Early research (Phase 1)Study completedNCT01053767
What this trial is testing

Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine

Who this might be right for
Group B Streptococcus (GBS) Disease
Novartis Vaccines 95
Not applicableStudy completedNCT00575653
What this trial is testing

Safety Study of GBS Following Menactra Meningococcal Vaccination

Who this might be right for
Guillain-Barre Syndrome
Harvard Pilgrim Health Care 6,000,000
Large-scale testing (Phase 3)Study completedNCT04752566
What this trial is testing

Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome

Who this might be right for
Guillain-Barre Syndrome
Alexion Pharmaceuticals, Inc. 57
Not applicableStudy completedNCT02143154
What this trial is testing

Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis

Who this might be right for
GBS PositiveWomen in Labor Given Vancomycin for Prophylaxis
Women and Infants Hospital of Rhode Island 77
Not applicableLooking for participantsNCT06615622
What this trial is testing

Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.

Who this might be right for
Guillain Barré SyndromeChronic Inflammatory Demyelinating PolyradiculoneuropathyPeripheral Nerve Disorder+2 more
Assiut University 90
Not applicableNot Yet RecruitingNCT07121985
What this trial is testing

Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
CIDP - Chronic Inflammatory Demyelinating PolyneuropathyGuillain-Barré Syndrome (GBS)
University of Erlangen-Nürnberg Medical School 30
Testing effectiveness (Phase 2)Study completedNCT02493725
What this trial is testing

JET-GBS - Japanese Eculizumab Trial for GBS

Who this might be right for
Gullain Barre Syndrome
Chiba University 34
Early research (Phase 1)Study completedNCT04035135
What this trial is testing

A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)

Who this might be right for
Guillain-Barré Syndrome
Annexon, Inc. 14